Endometriosis Global Clinical Trials Market Review Report 2026: Region, Country (G7 & E7), Phase, Trial Status, End Points Status And Sponsor Type

(MENAFN- GlobeNewsWire - Nasdaq) The report identifies market opportunities by analyzing global clinical trials on Endometriosis, focusing on top trial numbers, geographic regions, and prominent drugs in progress. It highlights key investment areas, cost-efficient trial locations, and provides insights on enrollment trends and trial success rates.

Dublin, May 11, 2026 (GLOBE NEWSWIRE) -- The "Endometriosis - Global Clinical Trials Review, 2026" clinical trials has been added to ResearchAndMarkets's offering.
The clinical trial report provides an overview of Endometriosis Clinical trials scenario. This report provides top line data relating to the clinical trials on Endometriosis.

Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials).

The analyst Clinical Trial Reports are generated using the analyst's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Report Scope

• The report provides a snapshot of the global clinical trials landscape
• Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
• The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
• The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
• The Report provides enrollment trends for the past five years
• Report provides latest news for the past three months

Latest Clinical Trials News on Endometriosis

• Mar 26, 2026: BioInvent achieves Phase 3 milestone for HMI-115 in endometriosis
• Mar 23, 2026: EndoCyclic Therapeutics Announces FDA Clearance of IND Application for ENDO-205, Non-Hormonal Precision Peptide Therapeutic for Endometriosis
• Mar 12, 2026: Gesynta Pharma doses first patient in Phase II NOVA trial
• Mar 04, 2026: Ananda Pharma: MHRA and NHS Ethics Approval Received for Endocan Phase 2 Clinical Trial for Endometriosis

Top Companies Participating in Endometriosis Therapeutics Clinical Trials

• AbbVie Inc
• Bayer AG
• Ferring Holding SA
• Neurocrine Biosciences Inc
• Kissei Pharmaceutical Co Ltd
• Pfizer Inc
• Takeda Pharmaceutical Co Ltd
• Abbott Laboratories
• Astellas Pharma Inc
• Bio-Innova Co Ltd

For more information about this clinical trials report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN11052026004107003653ID1111097814